We are live on ! Find out more
MTFB

Motif Bio plc ADRs
MTFB

Delisted

MTFB was delisted on the 16th of December, 2019.

0 hedge funds and large institutions have $0 invested in Motif Bio plc ADRs in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 60 (-6)

100% less capital invested

Capital invested by funds: $455K → $0 (-$455K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
Holders Change
-6
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
-$393K -1,090,800 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
-$37K -102,845 Closed
VF
3
Virtu Financial
New York
-$10K -27,161 Closed
Citadel Advisors
4
Citadel Advisors
Florida
-$9K -24,785 Closed
Deutsche Bank
5
Deutsche Bank
Germany
-$5K -16,483 Closed
UBS Group
6
UBS Group
Switzerland
-$1K -2,994 Closed

MTFB Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q4 2019, worth a combined $0 — down 100% from $455K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MTFB and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Invesco, exiting entirely with an estimated $393K sold.

  • 0 institutional investors held Motif Bio plc ADRs (MTFB) as of Q4 2019, down from 6 in Q3 2019.
  • Funds reported $0 of Motif Bio plc ADRs stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Motif Bio plc ADRs positions in Q4 2019 and 6 closed out, a net change of -6 holders.
  • The largest Motif Bio plc ADRs seller in Q4 2019 was Invesco, an estimated $393K sold.

Based on aggregated 13F filings for Q4 2019.